Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction

Acute myocardial infarction (AMI) is still a huge danger to human health. Sensitive markers are necessary for the prediction of the risk of AMI and would be beneficial for managing the incidence rate. N6-methyladenosine (m6A) RNA methylation regulators have been confirmed to be involved in the devel...

Full description

Saved in:
Bibliographic Details
Main Authors: Xianpei Wang, Ying Wu, Ruoyao Guo, Linwei Zhao, Juanjuan Yan, Chuanyu Gao
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2022/5173761
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554710723198976
author Xianpei Wang
Ying Wu
Ruoyao Guo
Linwei Zhao
Juanjuan Yan
Chuanyu Gao
author_facet Xianpei Wang
Ying Wu
Ruoyao Guo
Linwei Zhao
Juanjuan Yan
Chuanyu Gao
author_sort Xianpei Wang
collection DOAJ
description Acute myocardial infarction (AMI) is still a huge danger to human health. Sensitive markers are necessary for the prediction of the risk of AMI and would be beneficial for managing the incidence rate. N6-methyladenosine (m6A) RNA methylation regulators have been confirmed to be involved in the development of various diseases. However, their function in AMI has not been fully elucidated. The purpose of this study was to determine the expression of m6A RNA methylation regulators in AMI as well as their possible functions and prognostic values. The GEO database was used to get the gene expression profiles of patients with and without AMI, and bioinformatics assays of genes with differently expressed expression were performed. We establish two separate m6A subtypes, and relationships between subtypes and immunity were studied. In this study, we identified IGF2BP1, FTO, RBM15, METTL3, YTHDC2, FMR1, and HNRNPA2B1 as the seven major m6A regulators. A nomogram model was developed and confirmed. The consensus clustering algorithm was conducted to categorize AMI patients into two m6A subtypes from the identified m6A regulators. Patients who have activated T-cell activities were found to be in clusterA; they may have a better prognosis as a result. Importantly, we found that patients with high METTL3 expressions had an increased level of Activated.CD4.T.cell and Type.2.T.helper.cell, while having a decreased level of CD56bright.natural.killer.cell, Macrophage, Monocyte, Natural.killer.cell, and Type.17.T.helper.cell. Overall, a diagnostic model of AMI was established based on the genes of IGF2BP1, FTO, RBM15, METTL3, YTHDC2, FMR1, and HNRNPA2B1. Our investigation of m6A subtypes may prove useful in the developments of therapy approaches for AMI.
format Article
id doaj-art-6a8d243cb47946cbae0105253f18d551
institution Kabale University
issn 2314-7156
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-6a8d243cb47946cbae0105253f18d5512025-02-03T05:50:45ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/5173761Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial InfarctionXianpei Wang0Ying Wu1Ruoyao Guo2Linwei Zhao3Juanjuan Yan4Chuanyu Gao5Department of CardiologyHenan Provincial Key Lab for Control of Coronary Heart DiseaseDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyAcute myocardial infarction (AMI) is still a huge danger to human health. Sensitive markers are necessary for the prediction of the risk of AMI and would be beneficial for managing the incidence rate. N6-methyladenosine (m6A) RNA methylation regulators have been confirmed to be involved in the development of various diseases. However, their function in AMI has not been fully elucidated. The purpose of this study was to determine the expression of m6A RNA methylation regulators in AMI as well as their possible functions and prognostic values. The GEO database was used to get the gene expression profiles of patients with and without AMI, and bioinformatics assays of genes with differently expressed expression were performed. We establish two separate m6A subtypes, and relationships between subtypes and immunity were studied. In this study, we identified IGF2BP1, FTO, RBM15, METTL3, YTHDC2, FMR1, and HNRNPA2B1 as the seven major m6A regulators. A nomogram model was developed and confirmed. The consensus clustering algorithm was conducted to categorize AMI patients into two m6A subtypes from the identified m6A regulators. Patients who have activated T-cell activities were found to be in clusterA; they may have a better prognosis as a result. Importantly, we found that patients with high METTL3 expressions had an increased level of Activated.CD4.T.cell and Type.2.T.helper.cell, while having a decreased level of CD56bright.natural.killer.cell, Macrophage, Monocyte, Natural.killer.cell, and Type.17.T.helper.cell. Overall, a diagnostic model of AMI was established based on the genes of IGF2BP1, FTO, RBM15, METTL3, YTHDC2, FMR1, and HNRNPA2B1. Our investigation of m6A subtypes may prove useful in the developments of therapy approaches for AMI.http://dx.doi.org/10.1155/2022/5173761
spellingShingle Xianpei Wang
Ying Wu
Ruoyao Guo
Linwei Zhao
Juanjuan Yan
Chuanyu Gao
Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction
Journal of Immunology Research
title Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction
title_full Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction
title_fullStr Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction
title_full_unstemmed Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction
title_short Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction
title_sort comprehensive analysis of n6 methyladenosine rna methylation regulators in the diagnosis and subtype classification of acute myocardial infarction
url http://dx.doi.org/10.1155/2022/5173761
work_keys_str_mv AT xianpeiwang comprehensiveanalysisofn6methyladenosinernamethylationregulatorsinthediagnosisandsubtypeclassificationofacutemyocardialinfarction
AT yingwu comprehensiveanalysisofn6methyladenosinernamethylationregulatorsinthediagnosisandsubtypeclassificationofacutemyocardialinfarction
AT ruoyaoguo comprehensiveanalysisofn6methyladenosinernamethylationregulatorsinthediagnosisandsubtypeclassificationofacutemyocardialinfarction
AT linweizhao comprehensiveanalysisofn6methyladenosinernamethylationregulatorsinthediagnosisandsubtypeclassificationofacutemyocardialinfarction
AT juanjuanyan comprehensiveanalysisofn6methyladenosinernamethylationregulatorsinthediagnosisandsubtypeclassificationofacutemyocardialinfarction
AT chuanyugao comprehensiveanalysisofn6methyladenosinernamethylationregulatorsinthediagnosisandsubtypeclassificationofacutemyocardialinfarction